ArticlebioRxiv : the preprint server for biology2025
The serotonin 1B receptor modulates striatal activity differentially based on behavioral context.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
3 authors.
Funding
Abstract
The dorsomedial striatum (DMS) is critical for goal-directed behavior and has been implicated in both motivating and inhibiting behavioral responses. The DMS circuitry is complex as it integrates multiple inputs from the cortex, thalamus, and other subcortical structures including midbrain dopamine neurons. Though less studied, serotonin neurons from the dorsal raphe nucleus also richly innervate the DMS, which expresses the majority of the 14 receptor subtypes for serotonin. In particular, slice electrophysiology shows that the serotonin 1B receptor (5-HT1BR) impacts DMS physiology and plasticity, and behavioral experiments show that 5-HT1BR expression modulates impulsivity and other DMS-dependent reward-related behaviors. In these studies, our goal was to investigate the effects of 5-HT1BR on the DMS in vivo during goal-directed behavior in mice. Using a genetic 5-HT1BR loss-of-function model, we examined the calcium activity of individual medium spiny neurons (MSNs) in the DMS during operant tasks of responding and waiting. We found that knockout of 5-HT1BRs resulted in a significant reduction of excitatory calcium responses and an increase in the proportion of cells with inhibitory calcium responses following receipt of a reward. This suggests that serotonin may recruit MSN activity in response to reward via actions at 5-HT1BRs. On the other hand, in a behavioral paradigm designed to test impulsivity, we found that serotonin may inhibit DMS calcium activity through 5-HT1BRs. Specifically, mice lacking 5-HT1BR expression had a larger proportion of cells showing increased calcium responses during the waiting period of the trial, compared to controls. These results point to the importance of in vivo studies to understand the functional role of DMS serotonin in reward-related behavior. Overall our results demonstrate that serotonin can modulate the DMS in a behavioral state-specific manner, potentially providing a mechanism for how serotonin effects on behavior are context-dependent.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.